Search
Searching Content indexed under Patent by Gowling WLG ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4 5 6 7 8 9 10 11 . . .  
>>Next
 
Title
Country
Organisation
Author
Date
1
London Design Festival: Design Protection - Hindsight Giving Insight
Welcome to this our fifth annual event as part of the London Design Festival.
UK
10 Nov 2017
2
PMPRB Decision Creates Uncertainty For Patentees
On September 27, 2017, a two-member Hearing Panel of the Patented Medicine Price Review Board (PMPRB) ruled that the ultra-rare disease drug Soliris® (eculizumab), manufactured by Alexion Pharmaceuticals Inc. (Alexion), was "excessively priced." The Panel ordered both a reduction of the price of Soliris going forward and required Alexion to pay past "excessive" revenues.
Canada
8 Nov 2017
3
Singapore High Court Has No Original Jurisdiction To Revoke A Patent
For years, defendants in patent infringement proceedings have brought counterclaims for revocation of the patent. However, a recent High Court judgment indicates that this is no longer possible.
Singapore
31 Oct 2017
4
Defects In Pre-Patent Issue Process Do Not Render A Patent Void
In Apotex Inc. v Pfizer Inc. et al, 2017 FCA 201, the Federal Court of Appeal refused to void a patent based on an administrative error made during the prosecution of the patent application...
Canada
25 Oct 2017
5
Actavis v Eli Lilly: The Doctrine Of Equivalents In The UK, France And Germany
In view of the UK Supreme Court's judgment in Actavis v Eli Lilly, when will an 'equivalent' infringe as an immaterial variant?
Worldwide
11 Oct 2017
6
UK Rewrites Its Law Prohibiting Threats Of Legal Proceedings For IP Infringement
The Intellectual Property (Unjustified Threats) Act 2017 (the "Act") entered into force on 1 October 2017, introducing changes to the law in the UK regarding threats of intellectual property proceedings.
UK
9 Oct 2017
7
Actavis V Eli Lilly - What Is "Normal Interpretation"?
In a landmark decision (Actavis v Eli Lilly), the UK Supreme Court has re-steered the law of patent infringement in the UK, stating that there is a doctrine of equivalents.
UK
2 Oct 2017
8
Inutility Finding Overturned By Federal Court Of Appeal In First Application Of Supreme Court's Esomeprazole Decision
Dasatinib is the active ingredient in Bristol-Myers Squibb's (BMS) SPRYCEL®, indicated for the treatment of chronic myeloid leukemia in adults.
Canada
28 Sep 2017
9
Actavis V Eli Lilly - Should We Have Seen It Coming?
The UK Supreme Court's 12 July 2017 judgment in Actavis v Eli Lilly is undoubtedly a landmark decision, re-steering UK law regarding patent infringement by introducing a doctrine of equivalents.
UK
25 Sep 2017
10
EU Commission Wants To Have Its GI Protected Parmesan And Eat It
With the 'Brexit' negotiations between UK and the 'EU27' ongoing, the European Commission has published a position paper on intellectual property rights.
Canada
14 Sep 2017
11
How To Protect Your Design Rights
When it comes to design protection, there are different rights - all of which can be used to protect different aspects of a design.
UK
14 Sep 2017
12
High Court Gives Ground-Breaking Declaratory Relief Judgment In Favour Of Fujifulm Kyowa Kirin Biologics (FKB) And Gowling WLG
The March 2017 High Court judgment granted declaratory relief to FKB, which was attempting to launch a product and protect it against later, as yet ungranted, patent applications by AbbVie Technology.
Canada
12 Sep 2017
13
The Singapore Court Of Appeal Rules On Post Grant Amendments To Patents And Validity Of Second Medical Use Claims
On 21 April 2015, Warner-Lambert commenced an action against Novartis in Singapore for infringement of its Patent.
Singapore
18 Aug 2017
14
Canada's Patented Medicines Regime: Trending Upward And Onward
On July 14, 2017, Health Canada released the Therapeutic Products Directorate Statistical Report 2016/2017 for the Patented Medicines (Notice of Compliance) Regulations and Data Protection.
Canada
17 Aug 2017
15
Draft Patent Rules Released For Public Consultation: Overview Of Key Changes
The Canadian Intellectual Property Office (CIPO) has released draft revisions to the Patent Rules for public consultation.
Canada
16 Aug 2017
16
Certificates Of Supplementary Protection: Canada's New Sui Generis Patent Term Restoration Regime
We previously reported on Bill C-30 which made important changes to Canada's intellectual property landscape reflecting its commitments under the Comprehensive Economic and Trade Agreement between CETA.
Canada
8 Aug 2017
17
Curtain Lifted On Proposed Amended PM(NOC) Regulations
The curtain has been lifted to reveal the proposed amendments to the Patented Medicines (Notice of Compliance) Regulations (the "Amended Regulations") that have been a long-awaited result of CETA.
Canada
26 Jul 2017
18
UK Supreme Court Introduces Doctrine Of Equivalents In Patent Law In Actavis v Lilly
In a landmark decision (Actavis v Eli Lilly), the UK Supreme Court has re-steered the law of patent infringement in the UK, stating that there is a doctrine of equivalents.
UK
24 Jul 2017
19
$644 Million Patent Infringement Judgment Is Largest In Canadian History
In its decision in The Dow Chemical Company v. Nova Chemicals Corporation, 2017 FC 637, the Federal Court of Canada has awarded the successful plaintiff (Dow Chemical) over $644,000,000...
Canada
21 Jul 2017
20
Supreme Court Of Canada Rejects The Promise Of The Patent Doctrine
The Promise Doctrine required patentees to establish arguable statements of utility in the patent disclosure or risk losing their patents.
Canada
13 Jul 2017
Links to Result pages
 
1 2 3 4 5 6 7 8 9 10 11 . . .  
>>Next